3SBio Inc.
TRSBF
$0.8279
$0.104814.49%
Weiss Ratings | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | B | |||
Rating Factors | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.19 | |||
Price History | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 0.00% | |||
60-Day Total Return | 14.49% | |||
90-Day Total Return | 14.49% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | 3.49% | |||
2-Year Total Return | 3.49% | |||
3-Year Total Return | 3.49% | |||
5-Year Total Return | -42.10% | |||
52-Week High % Change | 0.00% | |||
52-Week Low % Change | 14.49% | |||
Price | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.83 | |||
52-Week Low Price | $0.72 | |||
52-Week Low Price (Date) | Sep 11, 2024 | |||
52-Week High Price (Date) | Dec 18, 2024 | |||
Valuation | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 2.27B | |||
Enterprise Value | 2.40B | |||
Price/Earnings (TTM) | 8.77 | |||
Earnings Per Share (TTM) | 0.09 | |||
Earnings Per Share Growth | -13.95% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.73 | |||
Price/Book (Q) | 0.99 | |||
Enterprise Value/Revenue (TTM) | 1.71 | |||
Price | $0.83 | |||
Enterprise Value/EBITDA (TTM) | 5.88 | |||
Enterprise Value/EBIT | 6.79 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 2.43B | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | 13.53% | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 86 24 2538 6000 | |||
Address | -- | |||
Website | www.3sbio.com | |||
Country | China | |||
Year Founded | 1993 | |||
Profitability | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 25.10% | |||
Profit Margin | 19.70% | |||
Management Effectiveness | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 5.64% | |||
Return on Equity | 10.46% | |||
Income Statement | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 1.17B | |||
Total Revenue (TTM) | 1.17B | |||
Revenue Per Share | $0.48 | |||
Gross Profit (TTM) | 1.00B | |||
EBITDA (TTM) | 338.50M | |||
EBIT (TTM) | 292.82M | |||
Net Income (TTM) | 229.80M | |||
Net Income Avl. to Common (TTM) | 229.80M | |||
Total Revenue Growth (Q YOY) | 12.25% | |||
Earnings Growth (Q YOY) | 8.64% | |||
EPS Diluted (TTM) | 0.09 | |||
EPS Diluted Growth (Q YOY) | 11.11% | |||
Balance Sheet | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 795.63M | |||
Cash Per Share (Q) | $0.33 | |||
Total Current Assets (Q) | 1.27B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 2.32B | |||
Current Ratio (Q) | 1.719 | |||
Book Value Per Share (Q) | $0.84 | |||
Total Assets (Q) | 3.30B | |||
Total Current Liabilities (Q) | 736.41M | |||
Total Debt (Q) | 579.86M | |||
Total Liabilities (Q) | 972.95M | |||
Total Common Equity (Q) | 1.98B | |||
Cash Flow | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -78.31M | |||
Cash from Financing (TTM) | -196.50M | |||
Net Change in Cash (TTM) | 1.68M | |||
Levered Free Cash Flow (TTM) | 229.82M | |||
Cash from Operations (TTM) | 275.78M | |||